Pharmaceuticals News and Research

RSS

Blood hormone may be key to appetite suppression and obesity control

How the body naturally regulates appetite through the presence of a blood hormone may offer the prospect of a safer and more effective method of weight control, according to Dr. Leonard Firestone of Manhattan Pharmaceuticals.

28 Jun 2004

Way for diabetics to regulate their blood-sugar levels whilst avoiding weight gain

Type 2 diabetics who take two drugs in combination with insulin can effectively regulate their blood-sugar levels without the common side effect of weight gain, according to a new study by researchers at UT Southwestern Medical Center at Dallas.

28 Jun 2004

A viral respiratory infection common in children increases the risk of developing asthma

The study, published in The Journal of Infectious Diseases, is the first to show a link between respiratory syncytial virus, or RSV, infection and asthma in mice. A related study, also in mice, suggests that a medication neutralizing the virus could decrease children's chances of developing asthma.

28 Jun 2004

Answers to childhood asthma may be in herbal medicine

A clinical trial to determine whether a herbal medicine can ease the symptoms of asthma in children is underway at RMIT University.

24 Jun 2004

Fewer Americans with Alzheimer’s and $149 billion in annual Medicare and Medicaid savings by 2025

A new Alzheimer’s Association report released today shows that medical research breakthroughs could result in nearly three million fewer Americans with the disease and $149 billion in annual Medicare and Medicaid savings by 2025.

24 Jun 2004

Findings from WHI memory study may not directly apply to newly menopausal women

The WHIMS article reported that estrogen therapy does not decrease, but may increase, the risk of probable dementia in women age 65 and older using hormones compared to women taking placebo.

23 Jun 2004

European marketing approval for new influenza vaccine

Solvay Pharmaceuticals announced today that it has obtained European marketing approval for its new virosomal influenza vaccine: INVIVAC®.

23 Jun 2004

Drug companies spend about 37% of their overall R&D budgets on clinical affairs

Over the last decade, clinical services industry growth has exploded. Today, study sponsors dedicate significant portions of their budgets to CROs, SMOs and patient recruiters to access the expertise needed to speed trials to safe and successful fruition.

23 Jun 2004

FDA to be sued by Mylan Laboratories

Mylan Laboratories Inc. today announced that it is filing suit against the Food and Drug Administration (FDA) in the U.S. District Court for the District of Columbia

23 Jun 2004

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).

23 Jun 2004

1 million deaths from malaria per year

Malaria remains a global health problem of staggering dimensions and despite many efforts to fight the disease; the situation today is worsening with more than 1 million deaths per year.

22 Jun 2004

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

Pharmaxis completes interim analysis on Bronchitol study

Sydney-based pharmaceutical company Pharmaxis Ltd has conducted an interim analysis on the Phase IIb clinical trial evaluating Bronchitol™ in patients with the respiratory condition bronchiectasis.

21 Jun 2004

DEA Controlled Substance Act Registration Database now on-line

The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.

21 Jun 2004

WHO removes two antiretroviral products from the WHO List of prequalified products

The World Health Organization (WHO) removed two antiretroviral products from the WHO List of prequalified products

20 Jun 2004

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

Regular use of beta-agonist drugs for asthma could be endangering their patients

Physicians who prescribe the regular use of beta-agonist drugs for asthma could be endangering their patients, two new studies by researchers at Cornell and Stanford universities find.

17 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Pulsed dye laser therapy not effective in treating acne

Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.

16 Jun 2004

Pharmaceuticals News and Research

Blood hormone may be key to appetite suppression and obesity control

Way for diabetics to regulate their blood-sugar levels whilst avoiding weight gain

A viral respiratory infection common in children increases the risk of developing asthma

Answers to childhood asthma may be in herbal medicine

Fewer Americans with Alzheimer’s and $149 billion in annual Medicare and Medicaid savings by 2025

Findings from WHI memory study may not directly apply to newly menopausal women

European marketing approval for new influenza vaccine

Drug companies spend about 37% of their overall R&D budgets on clinical affairs

FDA to be sued by Mylan Laboratories

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

1 million deaths from malaria per year

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Pharmaxis completes interim analysis on Bronchitol study

DEA Controlled Substance Act Registration Database now on-line

WHO removes two antiretroviral products from the WHO List of prequalified products

Drug for multiple sclerosis prevented disease development when tested on animal models

Regular use of beta-agonist drugs for asthma could be endangering their patients

Intrinsa patch increases sexual desire in menopausal women

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Pulsed dye laser therapy not effective in treating acne

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News